These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 30873584

  • 1. Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma.
    Hapgood G, Ben-Neriah S, Mottok A, Lee DG, Robert K, Villa D, Sehn LH, Connors JM, Gascoyne RD, Feldman AL, Farinha P, Steidl C, Scott DW, Slack GW, Savage KJ.
    Br J Haematol; 2019 Aug; 186(3):e28-e31. PubMed ID: 30873584
    [No Abstract] [Full Text] [Related]

  • 2. Small-cell pattern of DUSP22 rearranged ALK-negative anaplastic large-cell lymphoma with leukemic phase.
    Aarakaki H, Karube K.
    Blood; 2022 Jan 20; 139(3):465. PubMed ID: 35050329
    [No Abstract] [Full Text] [Related]

  • 3. Discovery of G6PD deficiency in a patient with DUSP22-rearranged ALK-negative anaplastic large cell lymphoma in leukemic phase.
    Anderson J, Putnam E, Liu W, Menon MP.
    Int J Lab Hematol; 2022 Feb 20; 44(1):67-68. PubMed ID: 34019742
    [No Abstract] [Full Text] [Related]

  • 4. Striking Association of Lymphoid Enhancing Factor (LEF1) Overexpression and DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma.
    Ravindran A, Feldman AL, Ketterling RP, Dasari S, Rech KL, McPhail ED, Kurtin PJ, Shi M.
    Am J Surg Pathol; 2021 Apr 01; 45(4):550-557. PubMed ID: 33165091
    [Abstract] [Full Text] [Related]

  • 5. Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements.
    King RL, Dao LN, McPhail ED, Jaffe ES, Said J, Swerdlow SH, Sattler CA, Ketterling RP, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Gibson SE, Ondrejka SL, Nicolae A, Macon WR, Dasari S, Parrilla Castellar E, Feldman AL.
    Am J Surg Pathol; 2016 Jan 01; 40(1):36-43. PubMed ID: 26379151
    [Abstract] [Full Text] [Related]

  • 6. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C, Chen X, Chen XY, He YH.
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct 08; 48(10):791-795. PubMed ID: 31594044
    [Abstract] [Full Text] [Related]

  • 7. Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma.
    Boddicker RL, Feldman AL.
    Biomark Med; 2015 Oct 08; 9(8):719-22. PubMed ID: 26223379
    [No Abstract] [Full Text] [Related]

  • 8. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER, Jaffe ES, Said JW, Swerdlow SH, Ketterling RP, Knudson RA, Sidhu JS, Hsi ED, Karikehalli S, Jiang L, Vasmatzis G, Gibson SE, Ondrejka S, Nicolae A, Grogg KL, Allmer C, Ristow KM, Wilson WH, Macon WR, Law ME, Cerhan JR, Habermann TM, Ansell SM, Dogan A, Maurer MJ, Feldman AL.
    Blood; 2014 Aug 28; 124(9):1473-80. PubMed ID: 24894770
    [Abstract] [Full Text] [Related]

  • 9. DUSP22-IRF4 rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphoma.
    Wang M, Kibbi N, Ring N, Siddon A, Foss F, Totonchy M.
    BMJ Case Rep; 2019 Sep 30; 12(9):. PubMed ID: 31570354
    [Abstract] [Full Text] [Related]

  • 10. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Chen BJ, Hsieh SM, Hsieh TH, Jhuang JY, Kao YC.
    Hum Pathol; 2024 Aug 30; 150():58-66. PubMed ID: 38971328
    [Abstract] [Full Text] [Related]

  • 11. Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements.
    Luchtel RA, Dasari S, Oishi N, Pedersen MB, Hu G, Rech KL, Ketterling RP, Sidhu J, Wang X, Katoh R, Dogan A, Kip NS, Cunningham JM, Sun Z, Baheti S, Porcher JC, Said JW, Jiang L, Hamilton-Dutoit SJ, Møller MB, Nørgaard P, Bennani NN, Chng WJ, Huang G, Link BK, Facchetti F, Cerhan JR, d'Amore F, Ansell SM, Feldman AL.
    Blood; 2018 Sep 27; 132(13):1386-1398. PubMed ID: 30093402
    [Abstract] [Full Text] [Related]

  • 12. DUSP22-rearranged ALK-negative anaplastic large cell lymphoma is a pathogenetically distinct disease but can have variable clinical outcome.
    Savage KJ, Slack GW.
    Haematologica; 2023 Jun 01; 108(6):1463-1467. PubMed ID: 36453106
    [No Abstract] [Full Text] [Related]

  • 13. Indolent ALK-negative anaplastic large-cell lymphoma, DUSP22 rearranged, with an unusual immunophenotype in a human immunodeficiency virus patient.
    Chapman J, Vega F.
    Histopathology; 2017 Jun 01; 70(7):1173-1175. PubMed ID: 28042680
    [No Abstract] [Full Text] [Related]

  • 14. "Double-hit" of DUSP22 and TP63 rearrangements in anaplastic large cell lymphoma, ALK-negative.
    Karube K, Feldman AL.
    Blood; 2020 Feb 27; 135(9):700. PubMed ID: 32106310
    [No Abstract] [Full Text] [Related]

  • 15. Peripheral T-cell lymphomas expressing CD30 and CD15 expand the spectrum of anaplastic large cell lymphoma, ALK-negative.
    Ganapathi KA, Nicolae A, Egan C, Geng H, Xi L, Pack SD, McFadden JR, Raffeld M, Jaffe ES, Pittaluga S.
    Br J Haematol; 2024 May 27; 204(5):1862-1871. PubMed ID: 38613165
    [Abstract] [Full Text] [Related]

  • 16. Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites.
    Zhang Y, Chen M, Yu Y, Liu X, Liu W, Jiang L, Zhang W.
    J Cutan Pathol; 2022 Feb 27; 49(2):187-190. PubMed ID: 34622970
    [Abstract] [Full Text] [Related]

  • 17. DUSP22 rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
    Qiu L, Tang G, Li S, Vega F, Lin P, Wang SA, Wang W, Iyer SP, Malpica L, Miranda RN, Konoplev S, Tang Z, Fang H, Medeiros LJ, Xu J.
    Haematologica; 2023 Jun 01; 108(6):1604-1615. PubMed ID: 36453104
    [Abstract] [Full Text] [Related]

  • 18. DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study.
    Pedersen MB, Hamilton-Dutoit SJ, Bendix K, Ketterling RP, Bedroske PP, Luoma IM, Sattler CA, Boddicker RL, Bennani NN, Nørgaard P, Møller MB, Steiniche T, d'Amore F, Feldman AL.
    Blood; 2017 Jul 27; 130(4):554-557. PubMed ID: 28522440
    [No Abstract] [Full Text] [Related]

  • 19. DUSP22 rearrangement in primary cutaneous T cell lymphoma with features intermediate between mycosis fungoides, anaplastic large-cell lymphoma and lymphomatoid papulosis.
    Diaz de la Pinta FJ, Machan S, Manso Alonso R, Carvajal N, Nieves Salgado R, Piris MA, Rodriguez-Pinilla SM.
    Histopathology; 2022 Jan 27; 80(2):446-449. PubMed ID: 34252219
    [No Abstract] [Full Text] [Related]

  • 20. DUSP22-rearranged anaplastic lymphomas are characterized by specific morphological features and a lack of cytotoxic and JAK/STAT surrogate markers.
    Onaindia A, de Villambrosía SG, Prieto-Torres L, Rodríguez-Pinilla SM, Montes-Moreno S, González-Vela C, Piris MA.
    Haematologica; 2019 Apr 27; 104(4):e158-e162. PubMed ID: 30361415
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.